BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19646143)

  • 1. Letter: Antiepileptogenic and neuroprotective effects of erythropoietin: recent data.
    Mikati MA; Mohler Cornett KM
    Epilepsia; 2009 Jun; 50(6):1654-5. PubMed ID: 19646143
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroprotection in epilepsy: the Holy Grail of antiepileptogenic therapy.
    Sankar R
    Epilepsy Behav; 2005 Dec; 7 Suppl 3():S1-2. PubMed ID: 16243002
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of steroids in epilepsy: time for a reappraisal?
    Watemberg N
    Isr Med Assoc J; 2010 Mar; 12(3):176-7. PubMed ID: 20684185
    [No Abstract]   [Full Text] [Related]  

  • 4. Erythropoietin in traumatic brain injury: the "golden bullet" on the horizon?
    Stahel PF; Flierl MA
    Neurol India; 2009; 57(6):693-4. PubMed ID: 20139494
    [No Abstract]   [Full Text] [Related]  

  • 5. Repurposed molecules for antiepileptogenesis: Missing an opportunity to prevent epilepsy?
    Klein P; Friedman A; Hameed MQ; Kaminski RM; Bar-Klein G; Klitgaard H; Koepp M; Jozwiak S; Prince DA; Rotenberg A; Twyman R; Vezzani A; Wong M; Löscher W
    Epilepsia; 2020 Mar; 61(3):359-386. PubMed ID: 32196665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editor review of "Erythropoietin as a neuroprotective agent in traumatic brain injury" by Mammis et al.
    Ausman JI
    Surg Neurol; 2009 May; 71(5):525. PubMed ID: 19386291
    [No Abstract]   [Full Text] [Related]  

  • 7. Meeting the challenge of treating epilepsy.
    Chadwick D; Wolf P
    Epileptic Disord; 2003 May; 5 Suppl 1():S7-8. PubMed ID: 12915335
    [No Abstract]   [Full Text] [Related]  

  • 8. [The renewing drug therapy of epilepsy].
    Keränen T; Kälviäinen R
    Duodecim; 1997; 113(18):1749-54. PubMed ID: 10892066
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic potential of thyreoliberin (TRH) and its analogues as antiepileptic and neuroprotective drugs].
    Jantas D
    Przegl Lek; 2010; 67(11):1179-85. PubMed ID: 21442973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection and antiepileptogenesis: where are we now?
    Dichter MA; Cole AJ
    Neurology; 2002 Nov; 59(9 Suppl 5):S36-8. PubMed ID: 12428031
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuroprotection and antiepileptogenesis: overview, definitions, and context.
    Cole AJ; Dichter M
    Neurology; 2002 Nov; 59(9 Suppl 5):S1-2. PubMed ID: 12428024
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuroprotection and parkinsonism.
    Gundersen V; Dietrichs E
    Can J Neurol Sci; 2000 Aug; 27(3):261. PubMed ID: 10975542
    [No Abstract]   [Full Text] [Related]  

  • 13. The role and potential mechanism of resveratrol in the prevention and control of epilepsy.
    Lu S; Wang X
    Future Med Chem; 2015; 7(15):2005-18. PubMed ID: 26505553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neuroprotective effect of erythropoietin in prevention of neuropsychiatric manifestation of SLE.
    Foroughinia F; Namazi S
    Med Hypotheses; 2007; 68(3):708-9. PubMed ID: 17064854
    [No Abstract]   [Full Text] [Related]  

  • 15. Fluorescein angiography findings strengthen the theoretical basis for trialling neuroprotective agents in cerebral malaria.
    Maude RJ; Beare NA
    Trends Parasitol; 2009 Aug; 25(8):350-1. PubMed ID: 19635680
    [No Abstract]   [Full Text] [Related]  

  • 16. From neurogenesis to neuroprotection in the epilepsy: signalling by erythropoietin.
    Castaneda-Arellano R; Beas-Zarate C; Feria-Velasco AI; Bitar-Alatorre EW; Rivera-Cervantes MC
    Front Biosci (Landmark Ed); 2014 Jun; 19(8):1445-55. PubMed ID: 24896364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin in Traumatic Brain Injury: An Answer Will Come Soon.
    Grasso G; Alafaci C; Buemi M
    World Neurosurg; 2015 Nov; 84(5):1491-2. PubMed ID: 26051375
    [No Abstract]   [Full Text] [Related]  

  • 18. Erythropoietin and Parkinson's disease: Suggested mechanisms and therapeutic implications.
    Genc K
    Med Hypotheses; 2008; 70(1):211-2. PubMed ID: 17553628
    [No Abstract]   [Full Text] [Related]  

  • 19. Resveratrol in epilepsy: preventive or treatment opportunities?
    Pallàs M; Ortuño-Sahagún D; Andrés-Benito P; Ponce-Regalado MD; Rojas-Mayorquín AE
    Front Biosci (Landmark Ed); 2014 Jun; 19(7):1057-64. PubMed ID: 24896336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eryrthropoietin and the promise of ischemic multiorgan protection.
    Stevens RD; Bhardwaj A
    Crit Care Med; 2008 Aug; 36(8):2446-7. PubMed ID: 18664794
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.